A Review of the Current Status and Prospects of Nanotechnology in the Advancement of Cancer Therapy

Therapy for melanoma, a type of skin cancer, is very challenging due to its tumor microenvironment, resistance, and spread. Advances in nanotechnology have led to the creation of nanocarriers, which decrease systemic toxicity and increase drug delivery precision. These tools address problems like poor tumor penetration and drug resistance. However, there are still problems with regulatory approval processes, manufacturing scalability, and biocompatibility. Continuous interdisciplinary research is necessary to translate scientific discoveries into therapeutic treatment.